3Port F K, Hulbert T R, Wolfe R A, et al. Predlalys is Blood Pressure and Mortatcty Orsk in a National Sample of Maintenance Hemodialysis Patients[J].Am J Kidney Dis, 1999,33 (3) :507-517.
4Santoro A, Mancini E, Basile C, et al. Blood Volume Contr Olled Hemodialysis in Hyptension-prone Patients a Rando [J]. Mized Multieater Controlled Frial Kidney Int, 2002,1034- 1045.
5De santo N G, Dirillo M, Perna A, et al. The Heart in Ceremia:Role of Hypertension, Hypotension, and Sceep Apnea [J]. Am J Kidney Dis,2001,38(4s) :38-46.
6Esehbach JW,E grie J,D own MR, et al. Correction of the an em ia o f end stage renal disease with recombinant human ery tb ro pi oe nn,resu|to fa e ombined phasea nde linicalt rial[J].Ne w E ng lj bled.1987,316(1);73-78.
7VaziriN D.M echanism ofc rythorpoietin-induced hypertension [J] . A m l K idney Dis,1999.33(5):821-828.
8ParkerK P,Mitch WE,S tivelman JC,eta l. Safety and efficacy of low do ses ubcutaneouse rythropoletini n hemodialysisp atients E1 l JA m S - Nephr. 1,1997,8(5): 288-293.
